Clinical trial
A Prospective, Multicenter, Single-Arm Study With Objective Performance Criteria Evaluating the Efficacy and Safety of PoliaValve® Artificial Heart Valve
NCT07123766 is registered in ClinicalTrials.gov with Suzhou Hearthill Medical Technology Co.,LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single-Arm Study With Objective Performance Criteria Evaluating the Efficacy and Safety of PoliaValve® Artificial Heart Valve
- Lead sponsor
- Suzhou Hearthill Medical Technology Co.,LTD
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 15, 2025
- Completion date
- December 30, 2027
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve diseases, aortic valve regurgitation, aortic valve stenosis